BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9345429)

  • 1. T cell response to two immunodominant proteolipid protein (PLP) peptides in multiple sclerosis patients and healthy controls.
    Pelfrey CM; Tranquill LR; Vogt AB; McFarland HF
    Mult Scler; 1996 Apr; 1(5):270-8. PubMed ID: 9345429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel T cell epitope of human proteolipid protein (residues 40-60) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients.
    Pelfrey CM; Trotter JL; Tranquill LR; McFarland HF
    J Neuroimmunol; 1993 Jul; 46(1-2):33-42. PubMed ID: 7689593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant.
    Ohashi T; Yamamura T; Inobe J; Kondo T; Kunishita T; Tabira T
    Int Immunol; 1995 Nov; 7(11):1771-8. PubMed ID: 8580075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gender on T-cell proliferative responses to myelin proteolipid protein antigens in patients with multiple sclerosis and controls.
    Greer JM; Csurhes PA; Pender MP; McCombe PA
    J Autoimmun; 2004 Jun; 22(4):345-52. PubMed ID: 15120759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a second T cell epitope of human proteolipid protein (residues 89-106) recognized by proliferative and cytolytic CD4+ T cells from multiple sclerosis patients.
    Pelfrey CM; Trotter JL; Tranquill LR; McFarland HF
    J Neuroimmunol; 1994 Sep; 53(2):153-61. PubMed ID: 7520919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans.
    Markovic-Plese S; Fukaura H; Zhang J; al-Sabbagh A; Southwood S; Sette A; Kuchroo VK; Hafler DA
    J Immunol; 1995 Jul; 155(2):982-92. PubMed ID: 7541828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects.
    Trotter JL; Pelfrey CM; Trotter AL; Selvidge JA; Gushleff KC; Mohanakumar T; McFarland HF
    J Neuroimmunol; 1998 Apr; 84(2):172-8. PubMed ID: 9628460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surges of increased T cell reactivity to an encephalitogenic region of myelin proteolipid protein occur more often in patients with multiple sclerosis than in healthy subjects.
    Pender MP; Csurhes PA; Greer JM; Mowat PD; Henderson RD; Cameron KD; Purdie DM; McCombe PA; Good MF
    J Immunol; 2000 Nov; 165(9):5322-31. PubMed ID: 11046067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T cell immunity to proteolipid protein (PLP) in multiple sclerosis (MS): identification of DR2-associated PLP determinants and conserved TCR CDR3 motifs].
    Kondo T; Ohashi T
    Nihon Rinsho; 1994 Nov; 52(11):2940-5. PubMed ID: 7527867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls.
    Minohara M; Ochi H; Matsushita S; Irie A; Nishimura Y; Kira J
    Tissue Antigens; 2001 May; 57(5):447-56. PubMed ID: 11556969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic mice.
    Kawamura K; Yamamura T; Yokoyama K; Chui DH; Fukui Y; Sasazuki T; Inoko H; David CS; Tabira T
    J Clin Invest; 2000 Apr; 105(7):977-84. PubMed ID: 10841661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis.
    Martin R; Voskuhl R; Flerlage M; McFarlin DE; McFarland HF
    Ann Neurol; 1993 Oct; 34(4):524-35. PubMed ID: 7692808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
    Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
    Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCR repertoire to proteolipid protein (PLP) in multiple sclerosis (MS): homologies between PLP-specific T cells and MS-associated T cells in TCR junctional sequences.
    Kondo T; Yamamura T; Inobe J; Ohashi T; Takahashi K; Tabira T
    Int Immunol; 1996 Jan; 8(1):123-30. PubMed ID: 8671596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
    J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DQB1*0602 rather than DRB1*1501 confers susceptibility to multiple sclerosis-like disease induced by proteolipid protein (PLP).
    Kaushansky N; Altmann DM; David CS; Lassmann H; Ben-Nun A
    J Neuroinflammation; 2012 Feb; 9():29. PubMed ID: 22316121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells.
    Vergelli M; Kalbus M; Rojo SC; Hemmer B; Kalbacher H; Tranquill L; Beck H; McFarland HF; De Mars R; Long EO; Martin R
    J Neuroimmunol; 1997 Aug; 77(2):195-203. PubMed ID: 9258250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.